Cargando…

A Study on Plasma Prostaglandin E(2) Levels in Hepatitis B Carriers and Patients with Chronic Active Hepatitis

Prostaglandin E(2) (PGE(2)), one of the major prostaglandins synthesized in human monocyte and macrophage, is able to modulate T lymphocyte reactivity, such as lymphokine secretion and cytotoxicity. Some immunologic abnormalities such as alteration in the synthesis of PGE(2) by monocyte and macropha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Hong, Heo, Yeong Sang, Ahn, Kwan Yong, Lee, Yong Gi, Kim, Dae Ghon, Ahn, Deuk Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 1987
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534930/ https://www.ncbi.nlm.nih.gov/pubmed/3154830 http://dx.doi.org/10.3904/kjim.1987.2.2.170

Ejemplares similares

Impaired lnterleukin-2 Receptor Expression on Lymphocytes from Patients with Chronic Active Hepatitis Type B
por: Ahn, Deuk Soo, et al.
Publicado: (1989)

Trial of Specific Antigen-Mediated Leukocyte Adherence Inhibition Test in Patients with Chronic Active Hepatitis and Hepatitis B Carrier
por: Oh, Yong II, et al.
Publicado: (1986)

Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
por: Moon, Jin Chang, et al.
Publicado: (2015)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
por: Lee, Heung Bum, et al.
Publicado: (1997)

Long-Term Treatment Efficacy and Safety of Clevudine Therapy in Naïve Patients with Chronic Hepatitis B
por: Choung, Bum Su, et al.
Publicado: (2012)

Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naïve Patients with HBeAg Positive Chronic Hepatitis B
por: Kim, In Hee, et al.
Publicado: (2010)

Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression
por: Lim, Jung Hwa, et al.
Publicado: (2019)

Percutaneous Transcatheteral Biliary Biopsy (PTBB): – A Report of Two Cases –
por: Kim, Dae Ghon, et al.
Publicado: (1989)

Detection of swine hepatitis E virus in the porcine hepatic lesion in Jeju Island
por: Lee, Song-Hak, et al.
Publicado: (2007)

Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
por: Kim, Do Young, et al.
Publicado: (2013)

Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea
por: Kim, Hyeong Il, et al.
Publicado: (2012)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
por: Jung, Yeon Woo, et al.
Publicado: (2020)

Assessment of Hepatic Fibrosis Regression by Transient Elastography in Patients with Chronic Hepatitis B Treated with Oral Antiviral Agents
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012)

Hepatitis E virus as an emerging zoonotic pathogen
por: Park, Woo-Jung, et al.
Publicado: (2016)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Detection of hepatitis E virus genotypes 3 and 4 in pig farms in Korea
por: Kim, Yong-Hyun, et al.
Publicado: (2018)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
por: Shin, Haneulsaem, et al.
Publicado: (2019)

Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response
por: Kwon, Dae Hun, et al.
Publicado: (2013)

Cross-Species Transmission of Swine Hepatitis E Virus Genotype 3 to Rabbits
por: Han, Sang-Hoon, et al.
Publicado: (2020)

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
por: Ahn, Jem Ma, et al.
Publicado: (2015)

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
por: Ahn, Sang Hoon, et al.
Publicado: (2013)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
por: Woo, Hyun Young, et al.
Publicado: (2020)

Cross-Species Transmission of Rabbit Hepatitis E Virus to Pigs and Evaluation of the Protection of a Virus-like Particle Vaccine against Rabbit Hepatitis E Virus Infection in Pigs
por: Han, Sang-Hoon, et al.
Publicado: (2022)

Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea
por: Ju, Young Cheol, et al.
Publicado: (2021)

A Case of Methimazole-Induced Acute Hepatic Failure in A Patient With Chronic Hepatitis B Carrier
por: Kang, Hun, et al.
Publicado: (1990)

Hepatitis B Virus X Protein Regulates Hepatic Glucose Homeostasis via Activation of Inducible Nitric Oxide Synthase
por: Shin, Hye-Jun, et al.
Publicado: (2011)

Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
por: Kim, Mi Na, et al.
Publicado: (2016)

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Heo, Ja Yoon, et al.
Publicado: (2018)

Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
por: Jung, Kyu Sik, et al.
Publicado: (2014)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
por: Ahn, Sung Soo, et al.
Publicado: (2014)

Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers.
por: Alexander, J M, et al.
Publicado: (1999)

Prevalence of Hepatitis B e Antigen in Chronic HBV Carriers in North-central Nigeria
por: Forbi, Joseph C., et al.
Publicado: (2012)

The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011)

Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
por: Heo, Ja Yoon, et al.
Publicado: (2016)

Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study
por: Paik, Yong Han, et al.
Publicado: (2010)

Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study – (NCT05103020) – study protocol
por: Kim, Ji Su, et al.
Publicado: (2023)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

Influence of Transforming Growth Factor-β1 Gene Polymorphism at Codon 10 on the Development of Cirrhosis in Chronic Hepatitis B Virus Carriers
por: Yu, Sang Kyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sp095hdmr36otr0hq65huhe67b